About 1 in 3 people with psoriasis who achieved clear skin with biologic drugs still had underlying inflammation that may ...

A new study reveals psoriasis may increase the risk of obesity and fatty liver despite skin improvements Learn why managing ...

Stull said that a number of prescription treatments exist for topical psoriasis, such as steroids and injectable therapies, ...

Skin symptoms may clear with biologics in psoriasis, but hidden internal inflammation often persists, contributing to major health risks.

New psoriasis drug Zoryve approved. How to use & why Black American participation in clinical trials is vital for health ...

US claims data show patients with generalized pustular psoriasis (GPP) face up to a 4-fold higher mortality risk compared ...

Discover a study in which researchers examined three international cohorts of patients with moderate-to-severe psoriasis ...

Feb. 3, 2025 — Psoriasis is a chronic skin disease that manifests itself mainly with skin symptoms (dryness, itching, scaly skin, abnormal patches and plaques). It affects about 2% of the ...

Starjemza (ustekinumab-hmny) was approved by the FDA this week as a biosimilar to Stelara. 2 A pair of clinical trials ...

The study revealed the following findings: 36.3% of psoriasis patients had elevated high-sensitivity C-reactive protein ...

A new study highlights a significant medical concern for individuals suffering from psoriasis, revealing that even when skin ...

At least twice as many patients on the approved spesolimab dose maintain improvement in skin symptoms and quality of life ...